Cargando…
Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells
BACKGROUND: Despite great efforts to identify druggable molecular targets for AML, there remains an unmet need for more effective therapies. METHODS: An in silico screening was performed using Connectivity Maps to identify FDA-approved drugs that may revert an early leukaemic transformation gene sig...
Autores principales: | Cornet-Masana, Josep M., Banús-Mulet, Antònia, Carbó, José M., Torrente, Miguel Ángel, Guijarro, Francesca, Cuesta-Casanovas, Laia, Esteve, Jordi, Risueño, Ruth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796581/ https://www.ncbi.nlm.nih.gov/pubmed/31473184 http://dx.doi.org/10.1016/j.ebiom.2019.08.021 |
Ejemplares similares
-
Histamine receptor 1 is expressed in leukaemic cells and affects differentiation sensitivity
por: Cornet‐Masana, Josep M., et al.
Publicado: (2020) -
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia
por: Cuesta-Casanovas, Laia, et al.
Publicado: (2023) -
A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia
por: Carbó, José M., et al.
Publicado: (2023) -
Lysosome-mediated chemoresistance in acute myeloid leukemia
por: Cuesta-Casanovas, Laia, et al.
Publicado: (2022) -
Repositioning of bromocriptine for treatment of acute myeloid leukemia
por: Lara-Castillo, María Carmen, et al.
Publicado: (2016)